去年，Agenus Inc表现最佳的业务板块Non-cash royalty revenue实现营收108.59M美元。United States的营收贡献最高，去年达到113.16M美元。最近一个季度，截至2026-06-30，Agenus Inc表现最佳的业务板块Non-cash royalty revenue实现营收28.15M美元。United States的营收贡献最高，达到34.52M美元。

业务

营业收入

占比

年报

年报

单季报

Non-cash royalty revenue

Pre-commercial product revenue

Other services

Clinical product revenue

License fee and milestones

Recognition of deferred revenue

Research and development services

Royalty sales milestone

Recognition of deferred grant revenue

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

Non-cash royalty revenue

108.59M(95.09%)

100.98M(97.60%)

114.57M(73.30%)

45.28M(46.20%)

44.35M(15.00%)

47.55M(53.92%)

Pre-commercial product revenue

4.24M(3.71%)

--(--)

Other services

1.04M(0.91%)

2.00M(1.94%)

2.98M(1.91%)

10.51M(10.73%)

6.70M(2.27%)

4.62M(5.24%)

Clinical product revenue

334.00K(0.29%)

482.00K(0.47%)

116.00K(0.07%)

762.00K(0.78%)

587.00K(0.20%)

--(--)

License fee and milestones

--(--)

25.00M(15.99%)

5.00M(5.10%)

220.00M(74.41%)

22.86M(25.92%)

Recognition of deferred revenue

--(--)

12.21M(7.81%)

9.54M(9.73%)

22.36M(7.56%)

12.30M(13.95%)

Research and development services

--(--)

1.44M(0.92%)

1.68M(1.71%)

1.48M(0.50%)

754.00K(0.86%)

Royalty sales milestone

--(--)

25.25M(25.76%)

--(--)

Recognition of deferred grant revenue

--(--)

184.00K(0.06%)

91.00K(0.10%)

地区

营业收入

占比

年报

年报

单季报

United States

Rest of World

Rest of world

Europe (IMF) (region)

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

United States

113.16M(99.09%)

101.46M(98.06%)

153.34M(98.09%)

87.51M(89.27%)

288.96M(97.73%)

83.55M(94.76%)

149.36M(99.54%)

32.78M(89.13%)

Rest of World

1.04M(0.91%)

--(--)

10.51M(10.73%)

6.70M(2.27%)

4.62M(5.24%)

--(--)

Rest of world

--(--)

2.00M(1.94%)

2.98M(1.91%)

--(--)

Europe (IMF) (region)

--(--)

690.00K(0.46%)

4.00M(10.87%)